Lixte Biotechnology Announces the Closing of $4.19 Million Registered Direct Offering
March 02, 2021 10:30 ET
|
Lixte Biotechnology Holdings, Inc.
East Setauket, March 02, 2021 (GLOBE NEWSWIRE) -- Lixte Biotechnology Holdings, Inc. (Nasdaq: LIXT), a clinical-stage drug discovery company developing pharmacologically active drugs for use in...